These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7536634)

  • 1. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis.
    Peacock DJ; Banquerigo ML; Brahn E
    Cell Immunol; 1995 Feb; 160(2):178-84. PubMed ID: 7536634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis inhibition suppresses collagen arthritis.
    Peacock DJ; Banquerigo ML; Brahn E
    J Exp Med; 1992 Apr; 175(4):1135-8. PubMed ID: 1372645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF).
    Oliver SJ; Cheng TP; Banquerigo ML; Brahn E
    Cell Immunol; 1995 Dec; 166(2):196-206. PubMed ID: 7497521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol.
    Oliver SJ; Banquerigo ML; Brahn E
    Cell Immunol; 1994 Aug; 157(1):291-9. PubMed ID: 7518753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity correlates with growth of transplantable osteosarcomas in rats treated with cis-diammine dichloroplatinum or the angiogenesis inhibitor AGM-1470.
    Kido A; Tsujiuchi T; Morishita T; Tsutsumi M; Takahama M; Miyauchi Y; Mii Y; Tamai S; Konishi Y
    Jpn J Cancer Res; 1998 Oct; 89(10):1074-81. PubMed ID: 9849588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro.
    Schoof DD; Obando JA; Cusack JC; Goedegebuure PS; Brem H; Eberlein TJ
    Int J Cancer; 1993 Oct; 55(4):630-5. PubMed ID: 7691763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation of human B-lymphocyte proliferation by AGM-1470, a potent inhibitor of angiogenesis.
    Antoine N; Bours V; Heinen E; Simar LJ; Castronovo V
    J Natl Cancer Inst; 1995 Jan; 87(2):136-9. PubMed ID: 7535858
    [No Abstract]   [Full Text] [Related]  

  • 8. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
    Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of experimental antiangiogenic therapy.
    Brem H; Folkman J
    J Pediatr Surg; 1993 Mar; 28(3):445-50; discussion 450-1. PubMed ID: 7682259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delay in administration of CDDP until completion of AGM-1470 treatment enhances antimetastatic and antitumor effects.
    Morishita T; Miyauchi Y; Mii Y; Miura S; Honoki K; Aoki M; Kido A; Yoshimoto M; Tamai S; Tsutsumi M; Konishi Y
    Clin Exp Metastasis; 1999 Feb; 17(1):15-8. PubMed ID: 10390142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470.
    Berger AE; Dortch KA; Staite ND; Mitchell MA; Evans BR; Holm MS
    Agents Actions; 1993; 39 Spec No():C86-8. PubMed ID: 8273596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
    Castronovo V; Belotti D
    Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of coronary vasculitis in a murine model of Kawasaki disease using an angiogenesis inhibitor.
    Brahn E; Lehman TJ; Peacock DJ; Tang C; Banquerigo ML
    Clin Immunol; 1999 Jan; 90(1):147-51. PubMed ID: 9884364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lymphatic metastasis in a syngeneic rat fibrosarcoma model by an angiogenesis inhibitor, AGM-1470.
    Futami H; Iseki H; Egawa S; Koyama K; Yamaguchi K
    Invasion Metastasis; 1996; 16(2):73-82. PubMed ID: 9030242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary study in experimental antiangiogenic therapy of nasopharyngeal carcinoma with AGM-1470 (TNP-470).
    Qian CN; Min HQ; Lin HL; Hong MH; Ye YL
    J Laryngol Otol; 1998 Sep; 112(9):849-53. PubMed ID: 9876375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis in vivo by interleukin 12.
    Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
    J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potent angioinhibin AGM-1470 stimulates normal but not human tumoral lymphocytes.
    Antoine N; Daukandt M; Locigno R; Heinen E; Simar LJ; Castronovo V
    Tumori; 1996; 82(1):27-30. PubMed ID: 8623499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of AGM-1470 in an improved intracranial 9L gliosarcoma rat model.
    Wilson JT; Penar PL
    Neurol Res; 1994 Apr; 16(2):121-4. PubMed ID: 7913996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis.
    Brem H; Gresser I; Grosfeld J; Folkman J
    J Pediatr Surg; 1993 Oct; 28(10):1253-7. PubMed ID: 7505321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells.
    McLeskey SW; Zhang L; Trock BJ; Kharbanda S; Liu Y; Gottardis MM; Lippman ME; Kern FG
    Br J Cancer; 1996 May; 73(9):1053-62. PubMed ID: 8624263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.